Elif Ekinci ⁎, , Carel W Le Roux , Oren Steen , Kathryn J Lucas , Elena Startseva , Anna Unseld , Anita M Hennige
{"title":"在胰高血糖素/GLP-1 受体双重激动剂 survodutide(一种胰高血糖素/GLP-1 受体双重激动剂)II 期试验中,按性别和体重指数(BMI)对超重/肥胖患者进行分组分析","authors":"Elif Ekinci ⁎, , Carel W Le Roux , Oren Steen , Kathryn J Lucas , Elena Startseva , Anna Unseld , Anita M Hennige","doi":"10.1016/j.orcp.2024.09.090","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"18 5","pages":"Page S39"},"PeriodicalIF":2.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Subgroup analysis by gender and body mass index (BMI) in people living with overweight/obesity in the survodutide, a glucagon/GLP-1 receptor dual agonist, phase II trial\",\"authors\":\"Elif Ekinci ⁎, , Carel W Le Roux , Oren Steen , Kathryn J Lucas , Elena Startseva , Anna Unseld , Anita M Hennige\",\"doi\":\"10.1016/j.orcp.2024.09.090\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19408,\"journal\":{\"name\":\"Obesity research & clinical practice\",\"volume\":\"18 5\",\"pages\":\"Page S39\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity research & clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871403X2400190X\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity research & clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871403X2400190X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Subgroup analysis by gender and body mass index (BMI) in people living with overweight/obesity in the survodutide, a glucagon/GLP-1 receptor dual agonist, phase II trial
期刊介绍:
The aim of Obesity Research & Clinical Practice (ORCP) is to publish high quality clinical and basic research relating to the epidemiology, mechanism, complications and treatment of obesity and the complication of obesity. Studies relating to the Asia Oceania region are particularly welcome, given the increasing burden of obesity in Asia Pacific, compounded by specific regional population-based and genetic issues, and the devastating personal and economic consequences. The journal aims to expose health care practitioners, clinical researchers, basic scientists, epidemiologists, and public health officials in the region to all areas of obesity research and practice. In addition to original research the ORCP publishes reviews, patient reports, short communications, and letters to the editor (including comments on published papers). The proceedings and abstracts of the Annual Meeting of the Asia Oceania Association for the Study of Obesity is published as a supplement each year.